Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SkQ1 Ophthalmic Solution for Dry Eye Syndrome (VISTA-1)
NCT03764735Phase 3Completed
- Sponsor
- Mitotech
- Start
- Dec 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SkQ1 in dry eye syndrome (DED), sponsored by Mitotech. Started Dec 2018; status: completed.
02
Drugs
SkQ1
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03764735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764735.